about
Cutaneous sympathetic vasoconstrictor reflexes for the evaluation of interscalene brachial plexus block.Antithrombin treatment in patients with traumatic brain injury: a pilot study.Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome.Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.Hydrodynamics of the Certas™ programmable valve for the treatment of hydrocephalus.Acute neuro-endocrine profile and prediction of outcome after severe brain injury.Intracranial Hypertension due to Cerebral Venous Sinus Thrombosis following Head Trauma: A Report of Two Cases.Effects of prostacyclin on the early inflammatory response in patients with traumatic brain injury-a randomised clinical study.Clinical applications of intracranial pressure monitoring in traumatic brain injury : report of the Milan consensus conference.Severe traumatic brain injury management and clinical outcome using the Lund concept.Continuous interscalene brachial plexus block for postoperative analgesia following shoulder surgery.Tumor blood flow and the cytotoxic effects of estramustine and its constituents in a rat glioma model.Features of the Sinushunt and its influence on the cerebrospinal fluid system.The complications and the position of the Codman MicroSensor™ ICP device: an analysis of 549 patients and 650 Sensors.Infusion technique can be used to distinguish between dysfunction of a hydrocephalus shunt system and a progressive dementia.An outcome study of severe traumatic head injury using the "Lund therapy" with low-dose prostacyclin.Complications following cranioplasty using autologous bone or polymethylmethacrylate--retrospective experience from a single center.Naloxone and TRH affect regional blood flows in the anesthetized rabbit.Pulsatility in CSF dynamics: pathophysiology of idiopathic normal pressure hydrocephalus.Nitric oxide inhibition by L-NAME but not 7-NI induces a transient increase in cortical cerebral blood flow and affects the cerebrovasodilation induced by TRH.Severe traumatic brain injury: consequences of early adverse events.Severe traumatic brain injuries in Northern Sweden: a prospective 2-year study.The release of S-100B and NSE in severe traumatic head injury is associated with APOE ε4.Prostacyclin treatment normalises the MCA flow velocity in nimodipine-resistant cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study.Prostacyclin treatment in severe traumatic brain injury: a microdialysis and outcome study.Fluid therapy and the use of albumin in the treatment of severe traumatic brain injury.Inhalation of substance P and thiorphan: acute toxicity and effects on respiration in conscious guinea pigs.Predicting improvement after surgery for palmar hyperhidrosis.Absence of electroencephalographic seizure activity in patients treated for head injury with an intracranial pressure-targeted therapy.Are intracranial pressure wave amplitudes measurable through lumbar puncture?The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy.The efficacy of P6 acupressure with sea-band in reducing postoperative nausea and vomiting in patients undergoing craniotomy: a randomized, double-blinded, placebo-controlled study.Effective ICP reduction by decompressive craniectomy in patients with severe traumatic brain injury treated by an ICP-targeted therapy.The influence of bilateral electrical preganglionic sympathetic stimulation on intra- and extracranial blood flow.CSF pressure assessed by lumbar puncture agrees with intracranial pressure.Electromagnetic environmental influences on implanted deep brain stimulators.The apolipoprotein E epsilon4 allele and outcome in severe traumatic brain injury treated by an intracranial pressure-targeted therapy.S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy.Dynamics of brain tissue changes induced by traumatic brain injury assessed with the Marshall, Morris-Marshall, and the Rotterdam classifications and its impact on outcome in a prostacyclin placebo-controlled study.Prostacyclin influences the pressure reactivity in patients with severe traumatic brain injury treated with an ICP-targeted therapy.
P50
Q30922795-20C805D5-FAFE-403E-94B2-2935A97711DAQ31806172-BF24472D-0619-4190-82B9-B0F4088A3A49Q35489076-BF060F23-CC9E-412B-9471-54BC4A595687Q35783757-B01342BF-37F0-45A9-B9F6-86F5D618D196Q36068523-5417EC20-AE86-4B9B-AAF0-EEBA61670C3AQ36797731-17F5AB99-EAF1-4FED-917D-042CF8AF5514Q37251343-FB971924-D339-4FFA-8A2D-25873EBBD765Q37617331-C7AA50A2-84F0-40C4-B94B-CE192355012CQ38213568-3D7C47AA-10EF-4A0B-B979-77C6E25291D5Q38224038-F10F1073-28D4-4E91-A165-2428FC9E9059Q39440811-52D35320-EE21-4F34-925F-FBD27A707098Q41102428-34F92080-4534-4C2D-A604-901322A24B45Q41791036-F73454BD-5A50-40FA-A2AA-BCD3085451F7Q42248339-21F7DD74-FF48-472B-84D3-F0DC1399DF41Q42638852-75F86996-FEA6-4336-A47F-195E5915A2B1Q43573440-2983FF23-56F2-4269-929C-108856B00B92Q43654660-AF3E0590-2940-460C-874A-79580902C587Q43821660-840EECAA-6513-4CEF-A37E-0D16A1E6DD89Q44120818-479DD42E-5D5B-47DB-A34F-9624CFCEE195Q44512665-46E0ED5F-357E-455C-8841-E2B6ABDFDE63Q45384000-014A504A-F103-48B8-BF07-17C3DA5C3D2BQ45734495-8007492E-E79D-4685-8551-F1426F79C414Q45897535-EFF70B1C-6EF9-4203-AAA7-7AB6DF2966A2Q46059227-9F4CC52F-DCFE-400B-BB0F-A1FBE2904971Q46117757-A17D8534-B714-4547-B7E8-408F708A7379Q46302647-C710A2A5-0A87-49FB-BB28-6ECC5B944B87Q46346155-827E77CE-85DD-4766-A53D-9763EEA4DFACQ46346617-76C986B9-45B6-4317-8AC3-4D228669208BQ46401361-6918B229-A992-4E4C-ADF6-7C5283C7A02DQ47396572-02D4922B-1574-4695-8C0D-75E948336CC5Q47835453-C21B3316-29FD-4E89-A808-28309C76B4E1Q47850296-9EE10371-4F12-4130-9003-5ECAC11E01E8Q48121968-0CFC0A4A-2D8A-4259-AB21-990DDCA2E2A1Q48250274-FA6B066E-DFF2-4713-B0C7-DECBFC7CC8BCQ48315687-58E1654A-68B6-4A52-8756-42CFB682745FQ48410007-4B0C3AEC-9CF1-443C-9A23-0FEAE5C80A65Q48461849-3E10B430-68B8-4232-8C3E-3B8AF829AA76Q48522997-6F119545-B523-4250-A87A-31C4ED075D27Q48546211-DC0E7761-AFC8-4BBB-B750-19CF6C38D1B0Q48643160-DDD6D07D-4E55-4E18-B106-0D0E57E088FD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lars-Owe D Koskinen
@ast
Lars-Owe D Koskinen
@en
Lars-Owe D Koskinen
@es
Lars-Owe D Koskinen
@nl
Lars-Owe D Koskinen
@sl
type
label
Lars-Owe D Koskinen
@ast
Lars-Owe D Koskinen
@en
Lars-Owe D Koskinen
@es
Lars-Owe D Koskinen
@nl
Lars-Owe D Koskinen
@sl
prefLabel
Lars-Owe D Koskinen
@ast
Lars-Owe D Koskinen
@en
Lars-Owe D Koskinen
@es
Lars-Owe D Koskinen
@nl
Lars-Owe D Koskinen
@sl
P108
P106
P1153
7005948345
P21
P31
P496
0000-0003-3528-8502